In 225 patients with non-muscle invasive bladder cancer having BCG, symptom-guided dwell-time cuts (to 60 or 30 min) vs standard 120 min lowered urgency at week 6 (32% vs 49%) and week 9 systemic symptoms (30% vs 61%); completion was similar (38% vs 40%).
RCTn = 225
Munk et al. Symptom-guided reduction of BCG dwell time: findings from the north-REG randomized trial